Medical Care Technologies Executes (OTC PINK:MDCE) Executes on Approximately $250,000 in Non-Dilutive Capital Generated Through Subsidiary Operations

Rhea-AI Summary

Medical Care Technologies (OTC Pink: MDCE) generated approximately $250,000 in non-dilutive capital through subsidiary asset sales and related operating activities at Infinite Auctions and Real Game Used.

The company plans to use these funds for AI product development, commercialization and marketing, reducing corporate obligations, and supporting operational growth as part of a broader internal capital generation initiative.

AI-generated analysis. Not financial advice.

Positive

• Approximately $250,000 in non-dilutive capital generated through subsidiaries
• Proceeds expected to support AI product development initiatives
• Funds allocated to commercialization and marketing of MDCE offerings
• Capital earmarked for reduction of existing corporate obligations
• Supports operational growth initiatives via internal capital generation
• Management prioritizing subsidiary asset monetization in capital allocation strategy

Negative

• None.

Company prioritizes internal capital generation initiatives to support AI development, commercialization, and operational growth

MESA, AZ / ACCESS Newswire / May 26, 2026 / Medical Care Technologies, Inc. (OTC Pink:MDCE) ("MDCE" or the "Company"), a technology-focused company advancing AI-driven consumer and enterprise platforms, today announced that it has generated approximately $250,000 in non-dilutive capital through subsidiary asset sales and related operating activities.

The proceeds were generated through the Company's subsidiaries, Infinite Auctions and Real Game Used, through sports memorabilia, collectibles, memorabilia authentication-related activities, and associated asset monetization efforts.

The Company stated that this milestone represents an initial phase of its broader internal capital generation initiative, which management currently intends to prioritize as part of its capital allocation strategy where practical. MDCE also expects to continue evaluating additional subsidiary-owned asset monetization opportunities in the near term.

The Company expects these proceeds to support:

• AI product development initiatives

• commercialization and marketing of MDCE offerings

• reduction of existing corporate obligations

• operational growth initiatives

"Generating approximately $250,000 through internal asset monetization reflects our commitment to disciplined capital allocation and leveraging the value of our subsidiaries as we continue expanding our technology initiatives," said Marshall Perkins, CEO of Medical Care Technologies.

About Medical Care Technologies Inc.:

Medical Care Technologies Inc. (OTC Pink:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning healthcare, wellness, nutrition, lifestyle, and enterprise imaging analysis. The Company also operates wholly owned subsidiaries Infinite Auctions and Real Game Used.

Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding product development, commercialization, strategic expansion, and future business opportunities. Actual results may differ materially due to various risks and uncertainties, including development timelines, capital availability, market conditions, and regulatory considerations. The Company undertakes no obligation to update forward-looking statements except as required by law.

Investor / Media Contact:
Medical Care Technologies Inc.
1910 S Stapley Drive
Suite 221
Mesa, AZ 85204
+1 480-645-0750
info@medicalcaretechnologies.com

X: https://x.com/medicalcaretech
Website: https://medicalcaretechnologies.com/

SOURCE: Medical Care Technologies, Inc. (OTC PINK:MDCE)

View the original press release on ACCESS Newswire

FAQ

What capital did Medical Care Technologies (OTC Pink: MDCE) generate in May 2026?

Medical Care Technologies generated approximately $250,000 in non-dilutive capital through subsidiary operations. According to Medical Care Technologies, this capital came from asset sales and operating activities at Infinite Auctions and Real Game Used focused on sports memorabilia and related monetization.

How will MDCE use the $250,000 in non-dilutive capital from its subsidiaries?

MDCE plans to use the approximately $250,000 to support AI product development, commercialization, and operations. According to Medical Care Technologies, proceeds are earmarked for marketing, reducing existing corporate obligations, and funding broader operational growth initiatives.

What subsidiaries contributed to MDCE’s $250,000 internal capital generation?

The capital was generated through MDCE subsidiaries Infinite Auctions and Real Game Used. According to Medical Care Technologies, these businesses monetized sports memorabilia, collectibles, authentication-related activities, and associated assets to provide non-dilutive capital.

What strategy is MDCE following with its internal capital generation initiative?

MDCE is prioritizing a broader internal capital generation initiative focused on subsidiary asset monetization. According to Medical Care Technologies, management intends to emphasize this approach in capital allocation where practical and may evaluate additional subsidiary-owned asset monetization opportunities.

How does the new capital support MDCE’s AI development and commercialization plans?

The approximately $250,000 is expected to fund AI product development and commercialization of MDCE’s platforms. According to Medical Care Technologies, proceeds will back marketing efforts and operational growth tied to its AI-driven consumer and enterprise technology initiatives.